Peptide profiles.

Naturally occurring copper-binding peptide found in human plasma. Declines significantly with age. Influences over 4,000 genes. Strongest evidence base for topical skin applications.

28-amino acid immune-modulating peptide derived from the thymus gland. Approved in 70+ countries as Zadaxin. Among the most clinically validated peptides globally.

Pineal gland-derived tetrapeptide studied for telomere lengthening via telomerase activation. 40+ years of Russian research by Dr. Vladimir Khavinson. Under FDA review for Category 1 status.

Mitochondria-derived peptide discovered in 2015. Acts as an exercise mimetic by activating the same metabolic pathways triggered by physical activity. Levels naturally decline with age.

A proprietary AminoClub peptide blend formulated for skin rejuvenation, cellular repair, and anti-aging. Combines synergistic peptides targeting collagen synthesis, skin barrier function, and cellular regeneration.

A proprietary AminoClub peptide blend formulated for metabolic optimization, body composition, and longevity. Targets the GH axis, metabolic pathways, and cellular health simultaneously.

Mitochondria-targeted tetrapeptide that protects the inner mitochondrial membrane. Reduces oxidative stress and restores ATP production. In Phase II and III clinical trials for heart failure and Barth syndrome.

Topical SNARE-inhibiting peptide that reduces facial expression lines by decreasing muscle contraction intensity. Often called a Botox alternative. Multiple human RCTs with wrinkle reduction data.

Signal peptide that mimics collagen breakdown fragments to stimulate fibroblasts to produce collagen elastin and fibronectin. One of the most evidence-backed topical cosmetic peptides with replicated human RCT data.

Extended Argireline analogue with two additional amino acids for potentially greater SNARE inhibition at lower concentration. Often combined with Argireline for additive expression line reduction.

A synthetic tripeptide (Ala-Glu-Asp) from the Khavinson family of short peptide bioregulators. Studied in cell culture for cartilage matrix biology and connective tissue gene expression. Evidence is entirely preclinical — cell culture and gene expression studies from a single Russian research group. No human clinical trials exist as of 2026.

A copper-binding tripeptide in the same family as GHK-Cu but with a different amino acid sequence (Ala-His-Lys versus Gly-His-Lys). AHK-Cu is specifically studied for hair follicle stimulation, scalp health, and hair loss research — a more targeted application than GHK-Cu's broader skin and wound healing profile. Sometimes called Copper Peptide-3.

A small molecule NNMT (Nicotinamide N-methyltransferase) inhibitor — not technically a peptide, but a research compound widely carried by peptide vendors with significant interest in longevity and metabolic research communities. NNMT is an enzyme that consumes NAD+ precursors and promotes fat storage. Inhibiting it raises NAD+ levels and shifts metabolism toward fat burning. Animal data is promising. Human research is limited.

The body's master antioxidant — a tripeptide naturally produced in every cell, responsible for neutralizing free radicals, supporting detoxification, and regulating immune function. Levels decline with age and under chronic stress. Among the most researched compounds in this database with genuine human clinical trial data across multiple conditions. IV glutathione is widely used in longevity and integrative medicine clinics.

A synthetic tripeptide (Glu-Asp-Arg) derived from the pineal gland — part of the same Khavinson bioregulator family as Epitalon and Cartalax but targeting neuronal tissue specifically. Studied for neuroprotection, cognitive function, circadian rhythm regulation, and retinal protection. Russian clinical research from Dr. Khavinson's group spans several decades. English-language independent replication is limited.